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The objectives of this work are the isolation, purification, structure elucidation, 
and biological evaluation of bioactive secondary metabolites, primarily tannins and 
diterpenoids, of two plant species: silver maple (Acer saccharinum) and Euphorbia 
saudiarabica, respectively.  
Based on the ethnopharmacological literature, Acer saccharinum is a traditional 
medicinal plant that has been used by the people of North America. According to 
previous phytopharmacological studies by our group, over 70 phytochemicals, primarily 
tannins and flavonoids, have been discovered from three different maple species, 
including sugar (Acer saccharum), red (Acer rubrum), and sycamore (Acer 
pseudoplatanus) maples. Remarkably, the red maple species yielded very interesting 
bioactive (α-glucosidase inhibitors) glucitol-core containing gallotannins (GCGs). 
Therefore, to gain a better understanding of the phytochemical composition of other 
maple species, such as silver maple, the fresh leaves of silver maple were collected and 
extracted. Following this, the crude extracts of different polarities were prepared, and 
then all extracts initially screened using reversed-phase high-performance liquid 
chromatography (RP-HPLC) and thin-layer chromatography (TLC), and the Folin-
Ciocalteau assay for quantifying polyphenol contents. Then, the isolation procedure was 
carried out using multiple techniques, including open column chromatography (OCC), 
TLC, and RP-HPLC on the highest total polyphenol content extract (which was the ethyl 
acetate [EtOAc] extract). Using high-performance liquid chromatography with diode-
array detector (HPLC-DAD) analyses using previously isolated standards, nine 
compounds, including six GCGs, were identified as ginnalins A–C (1–3), maplexins B, 
 
D, and F (4–6), methyl syringate (7), methyl gallate (8), and 3-methoxy-4-
hydroxyphenol-1-β-D-(6-galloyl)-glucopyranoside (9). Additionally, pubineroid A 
(10), a sesquiterpenoid, was isolated and identified (by NMR). 
The Euphorbia genus is one of the six largest genera of flowering plants which 
are known to produce several bioactive secondary metabolites, primarily diterpenes 
such as jatrophane and lathyrane-type. Euphorbia saudiarabica, which is endemic to 
Saudi Arabia, is well characterized by the production of a milky irritant latex. It is one 
of the plant species in the region that has not been studied. To increase the knowledge 
of the constituents of E. saudiarabica, a comprehensive phytochemical investigation 
was conducted, leading to the isolation of five new lathyrane-type diterpenoids (1-5) 
named saudiarabicain A–E. These compounds were evaluated for their cytotoxic 
activities against three cell lines, including, murine B16F10 melanoma cells, human 
HaCat keratinocytes, and human SH-SY5Y neuroblastoma cells. In B16F10 melanoma 
cells, only compounds 2, 3, and 4 induced significant toxicity, with compound 2 having 
the greatest range of toxicity from 100 μM (49.63% decrease) to 20 μM (14.69% 
decrease). In human keratinocytes (HaCat), each compound caused a decrease in cell 
viability with concentrations above 40 μM. At a concentration of 30 μM, compounds 3 
and 4 caused reductions in cell viability by approximately 12.42% and 17.92%, 
respectively. Compound 3 was able to decrease viability by as much as 93.63% at 50 
μM. Lastly, in SH-SY5Y cells, all of thecompounds (1–5) induced a cytotoxic effect at 
concentrations of 50 μM and above.  
Lastly, for the first time, a qualitative analysis of the flavonoids present in a 
methanol extract of the aerial parts of E. saudiarabica using LC-ESI-TOF-MS/MS was 
 
conducted. This led to the identification of 36 flavonoids including 7 flavonoids based 
on the galangin aglycon, 9 flavonoids based on the apigenin aglycon, and 20 flavonoids 
originated from luteolin.  
In conclusion, this dissertation provids insights about the phenolic constituents, 
primarily tannins, of silver maple (Acer saccharinum), compared to other common 
maple species, mainly the sugar (A. saccharum), red (A.rubrum), and sycamore (A. 
pseudoplatanus) maples which were previously investigated by our group. In addition, 
the endemic Euphorbia saudiarabica species from Saudi Arabia yielded five new 
lathyrane-type of diterpenoids. All compounds evaluated for their cytotoxicity showed 
moderate effects. Lastly, a rapid and reliable method employing LC-ESI-TOF-MS/MS 
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“Guidelines for the Format of Thesis and Dissertations” standards for the manuscript 
format. This dissertation is composed of three manuscripts to satisfy the requirements 
of the Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, 
University of Rhode Island.  
MANUSCRIPT І: Bioactive Glucitol-Core Containing Gallotannins and Other 
Phytochemicals from Silver Maple (Acer saccharinum) Leaves. 
This manuscript was published in Natural Products Communication, 2017.    
The objective of this work was to investigate the secondary metabolites, primarily 
polyphenolic compounds, and especially, gallotannins. The presence of unique 
gallotannins-type compounds in several maple species, including sugar, red, and 
sycamore species, and their bioactivities, prompted us to seek for new gallotannin 
compounds and/or known compounds from silver maple leaves.  
 
MANUSCRIPT II: Saudiarabicain A–E, Macrocyclic Diterpenoids from 
Euphorbia saudiarabica. 
This manuscript will be submitted to the Journal of Natural Products. 
In this work, we investigated the phytochemical constituents of an endemic species from 
Saudi Arabia called Euphorbia saudiarabica. The genus Euphorbia is well known for 
its richness of secondary metabolites, primarily diterpenes, in their latex. The aerial parts 
of the plant were collected in 2014 in Saudi Arabia, where they are located in a colony 
close to the Red Sea. Next, it was extracted using methanol and sent to our laboratory 
viii 
for further investigation. Several steps of purification and structure characterization 
were conducted, resulting in the isolation of five new diterpenoids compounds named 
saudiarabicains A–E. These compounds were evaluated for their cytotoxicity against 
three cell lines including murine B16F10 melanoma cells, human HaCat keratinocytes, 
and human SH-SY5 neuroblastoma cells.  
 
 MANUSCRIPT III. Liquid Chromatography Coupled with Time-of-Flight 
Mass Spectrometry for Rapid Identification of Flavonoids from Aerial Parts 
of Euphorbia saudiarabica 
This manuscript will be submitted to the Journal of Separation Science. 
This work focused on the phenolic contents, mainly flavonoids, of Euphorbia 
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 All organisms are required to produce many organic compounds to enable 
them to live, grow, and reproduce. These organisms, such as plants, need to supply 
themselves with energy and sufficient amounts of building blocks to build up their 
tissues. Vast quantities of enzymes are involved in accelerating and regulating the 
chemical reactions that take place in organisms, and the pathways involved are 
called metabolic pathways. Carbohydrates, proteins, fats, and nucleic acids are some 
of the essential molecules for all organisms. Organisms differ broadly in their ability 
to synthesize and transform chemicals; plants are well known for their highly 
efficient synthesis of organic molecules. They produce these molecules through 
photosynthesis, a process through which light energy is converted into chemical 
energy that can be used to fuel energy transformations when they are needed later 
on. This diverse array of organic molecules, essential to plants, are called 
metabolites (1). 
 There are two types of metabolites: primary and secondary. The primary 
metabolites are all those organic compounds that are primarily involved in 
synthesizing and modifying the fundamental compounds of the plants including 
carbohydrates, proteins, fats, and nucleic acids, which are essential for vital 
processes such as glycolysis, fatty acid oxidation, carbohydrate degradation, etc. 
They, in other words, are all the metabolites that are directly involved in a plant’s 
normal growth, reproduction, and development. By contrast, the secondary 
metabolites have a much more limited distribution within the plant kingdom (2). 
Moreover, these types of metabolites are not necessarily produced in all plants 
because they are not directly involved in the plants’ vital processes. Although the 
benefits of these compounds are not yet known, there are nonetheless some plausible 
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reasons for plants to have these types of metabolites. They include providing defense 
against predators by producing toxic compounds and warning other species by 
producing coloring agents. Biosynthetically, secondary metabolites are derived from 
primary metabolites through many complex biochemical pathways. These 
metabolites can be found in any of the plants’ organs, such as their leaves, stem, 
bark, or roots. However, they may vary in their concentration based on their location 
in the plant. The secondary metabolites are also known as natural products (3). 
 Most of the pharmacological effects of a specific plant on humans or animals 
are due to the presence of one or more of these natural products, which are called 
bioactive natural products. The pharmacological effects of these products are many, 
such as therapeutic activities for diseases, or toxic activities responsible for human 
or animal illnesses. Furthermore, based on the secondary metabolites’ biosynthetic 
origins and their chemical structure, there are three main classes of compounds: 
terpenes and steroids, phenolics, and nitrogen-containing compounds (Fig. 1) (1,3,4). 
 













1- Phenolic compounds 
 Plants produce a vast variety of natural products such as phenolics, which 
contain a phenolic group that is chemically heterogeneous. Some of them are water 
soluble, others are soluble in organic solvents, and some are insoluble polymers. 
These phenolics have a very broad range of physiological roles in plants. For 
instance, some phenolics serve as a defense system against environmental stresses, 
including herbivores, pathogens, low temperatures, and nutrient deficiency. 
Phenolics arise biosynthetically via several different routes; however, the most 
important ones are the shikimic acid and malonic acids pathways. The shikimic acid 
pathway is the main route to produce most of the plant phenolics. It begins with a 
coupling of two start molecules: phosphoenolpyruvate (PEP) from the glycolytic 
pathway, and D-erythrose 4-phosphate from the pentose phosphate cycle. These two 
molecules produce a six-cyclic carbon compound with one carbon (COOH) side 
chain, namely shikimate, through an aldol-type condensation reaction. Then, several 
other complex transformations are formed to produce many different phenolic types 
(Fig. 2) (5). 
 






























 Tannins are a unique group of phenolic compounds called non-flavonoids, 
which have the capability to bind strongly with other secondary metabolites such as 
alkaloids, polysaccharides, and proteins. There are four main kinds of tannins, 
including: 
1.  Gallotannins, which are hydrolyzable tannins that galloyl units are 
attached to via several polyol residues.  
2.  Ellagitannins, which are hydrolyzable tannins. At least two galloyl units 
are attached to each other (C-C coupled) and are linked to D-glucosyl 
units.  
3.  Complex tannins, which are built up from a combination of either a 
gallotannin, a ellagitannin unit, or both, and a catechin unit.  
4. Condensed tannins, which are polymers of polyhydroxy-flavan-3-ol 
monomers (also known as proanthocyanidins). (6,7) 
Many of these tannins can be found in grape seeds, apple juice, strawberries, 
raspberries, pomegranates, walnuts, muscadine grapes, peaches, blackberries, etc.  
Flavonoids and their conjugate forms are one of the most abundant 
polyphenols; over 8000 different flavonoids have been reported. In addition, they 
are considered to be the most plentiful of natural products in human diet since they 
are found in many plant tissues, including fruits and vegetables. The basic chemical 
structure of flavonoids is a skeleton of diphenylpropane connected by a three-carbon 
chain “bridge” which is biosynthetically derived from two different pathways: the 
shikimic acid pathway and malonic acid pathway. The three carbon chain bonds with 
one oxygen linked to form a pyran ring (heterocyclic ring) with one phenyl ring 
(malonic acid derived) to eventually form the benzopyrano ring moiety. Therefore, 
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the skeletal structure of the flavonoid can be abbreviated C6-C3-C6 (Fig. 3). Thus, 
according to the position of the bond of the aromatic ring to the  
 
Figure 3. The skeletal structure of the flavonoids. 
benzopyrano moiety and the degree of oxidation of the three-carbon chain, this 
flavonoid can be divided into four main classes: the anthocyanins, the flavones, the 
flavonols, and the isoflavones (Fig. 4) (8). 
 
Figure 4. The skeletal structure of the four main classes of the flavonoid 
compounds. 
 
2- Terpenoid compounds 
The terpenoids, or the terpenes, are one of the most diverse classes of secondary 
metabolites. Most of them are known for their water insolubility. All terpenoids are 
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synthesized from acetyl-CoA or its glycolytic intermediates. Based on the number 
of isoprene units (C5) that are linked to each other, several sub-class of terpenes are 
produced as follows: 
A- Monoterpene compounds (C10) are formed from an infusion of two 
isoprene units such as menthol and linalool.  
B- Sesquiterpene compounds (C15) are composed of three isoprene units. 
C- Diterpene compounds (C20) are formed from four isoprene units. 
D- Triterpene compounds (C30) are formed from six isoprene units. 
E- Tetraterpene compounds (C40) are composed by the fusion of eight 
isoprene units.  
These terpenes are synthesized from primary metabolites by either the mevalonic 
acid pathway (MVA) or the methylerythritol phosphate (MEP) pathway. Most of the 
plant diterpenes, such as Euphorbia genus diterpenes, are produced through the MEP 
pathway. Most of the terpenes are known for their vital roles in plant growth, 
development, and defensive systems. Some of them are considered primary 
metabolites rather than secondary metabolites due to their fundamental role in plant 
life. For instance, sterols are essential components of cell membranes (9). 
Diterpenes biosynthetically arise from their geranylgeranyl diphosphate 
(GGPP) precursors, which are initially derived from four isoprene units. They can 
be found in two main types, which are: 
 




- Acyclic diterpenoids, such as phytol, the reduced form of geranylgeraniol 
that form the side-chain of the chlorophylls, and phytyl, which is found in 
vitamin K. 
- Cyclic diterpenoids, which are also subdivided into different types based on 
the number of rings systems present. For example, there are bicyclic 
diterpenoids such as labdane, tricyclic diterpenoids such as taxadiene, and 
tetracyclic diterpenoids such as stemodene (Fig. 6) (10). 
 
    Labdane                         Taxadiene                        Stemodene 
Figure 6. Different type of cyclic diterpenoids. 
These different types of cyclized diterpenoids are generated through different 
cyclization reactions of GGPP, which are mediated by carbocation formation, as 
well as by the potential of Wagner-Meerwein rearrangements. For instance, 
paclitaxel (an anti-cancer drug) starts by generating carbocation form at the 
beginning of the reaction (Fig. 7). 
 
                  
   Taxol 
Figure 7. Reaction mechanism for the cyclization of GGPP 
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Diterpenoids can be found either in higher plants or fungi. For example, phytol is 
widespread in higher plants, where it binds to chlorophyll structures. Most 
diterpenoids are restrictively distributed and are rarely attached to sugar moieties to 
form glycosidic diterpenoids. If it is present, it is recognized as a sweetening agent.  
3- Nitrogen-containing compounds 
       Many secondary metabolites have a nitrogen atom as part of their chemical 
structure. They include alkaloids, cyanogenic glycosides, glucosinolates, and non-
protein amino acids. Alkaloids, the most abundant N-containing natural products, 
and are found in more than 20% of plants. Usually, the nitrogen atom is part of the 
cyclic rings. Alkaloids synthesized mainly from amino acids are mostly lysine, 
tryptophan, or tyrosine. Furthermore, the carbon skeleton of many alkaloids can be 
derived biosynthetically from a terpene pathway. They can be produced by different 
organisms such as fungi, bacteria, and animals. Depending on the chemical features 
of the compounds, alkaloids can be classified into seven main types (Fig. 8) (2). 
 
 




Phytopharmacological investigation of maple (Acer) species  
Our laboratory has previously isolated a series of natural α-glucosidase 
inhibitory gallotannins, named maplexins A–I, from the red maple (Acer rubrum) 
species (11,12). These compounds contained mono-, di-, and trigalloyl substituents 
located at different positions on a 1,5-anhydro-D-glucitol moiety. Interestingly, the 
α-glucosidase inhibitory activities of these maplexins increased with the number of 
galloyl substituents, and a trigalloyl-substituted maplexin (maplexin E) was 20-fold 




Figure 9. The chemical structure of maplexins A–I 
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Phytopharmacological investigation of Euphorbia species 
 The Euphorbiaceae family is among the most prominent families of the higher 
plants, and is composed of more than 300 genera and 7000 species subdivided into 
many subgenera and sections (13). Among this family, the Euphorbia genus is one of 
the three largest genera of flowering plants, with approximately 2000 species (14). 
The Euphorbia species all produce a mostly white latex, which is often rich in 
secondary metabolites, some of which are considered toxic. Several Euphorbia 
species have been used in ethnomedicine as purgatives and as treatments for asthma, 
tumors, and warts. (13) It is also well known for producing various types of secondary 
metabolites, primarily diterpenes, with immense chemical diversity (15). Diterpenes 
occurring in the Euphorbia species are of considerable interest from the perspective 
of natural product drug discovery because of their wide range of unique biological 
activities and their high structural diversity. They have been reported to show a broad 
range of in vitro and in vivo biological properties, including multidrug resistance 
(MDR) modulator, antimicrobial, and anticancer agents. The importance of 
diterpenes from the Euphorbiaceae family is highlighted by the approval granted by 
the US Food and Drug Administration in 2012 for the treatment of actinic keratosis, 
a precancerous skin condition, of ingenol 3-angelate (ingenol mebulate, PEP005, 
Picato®, LEO pharma) (16). Ingenol mebutate is a substance derived from the sap of 
the plant Euphorbia peplus. The high presence of active diterpenes in the latex of 
many Euphorbia species is well known. Diterpenoids are the majority secondary 
metabolites of the Euphorbia genus with many different skeletons, such as 
jatrophanes, ingenane, and lathyranes (Fig. 10), as well as sesquiterpenoids, 
flavonoids, and steroids. Previous publications on diterpenoids isolated from 
Euphorbia species have revealed novel compounds with promising cytotoxicity and 
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MDR modularity effects, such as macrocyclic lathyrane and jatrophane diterpenes 
(13). Also, several structure-activity relationship studies on Euphorbia species have 
revealed that the diterpenoids with the jatrophanes and lathyrane pharmacophore are 
very active MDR modulators due to the high conformational flexibility of their 11, 
12-membered rings (Fig. 10) (17). A recent study also has shown that some 
Euphorbia species like E. resinifera and E. bicolor possess different structural 
compounds with various biological properties, such as an analgesic activity (18). 
 
Figure 10. The skeletal structure of three types of Euphorbia diterpenoids. 
A recent study has shown that the number of publications on the Euphorbia 
species increased by about 40% from 2012 to 2013 (14). In the past few years, several 
researchers have revealed that Euphorbia diterpenes with different skeletal types 
(such as tigliane, lathyrane, myrsinane, and jatrophane) have exhibited moderate or 
strong antiproliferative effects on different human cell lines (e.g., pancreatic, lung, 
skin, ovarian, and colon carcinomas). Some of these diterpenes have been 
demonstrated as cytotoxic compounds, and other as apoptosis inducers. For 
example, several lathyrane diterpenoids isolated from Euphorbia nivulia exhibited 
strong cytotoxicity effects against Colo205, MT2, and CEM cell lines (19). Many 
other diterpenes types, such as jatrophane, ingenane, premyrsinane and 
cyclomyrsinane derivatives, have shown potent cytotoxicity effects against various 
human cancer cell lines. A recent study has indicated that some jatrophane 
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diterpenes showed synergistic interactions with the anticancer drug doxorubicin (20). 
This dual action was the result of the high flexibility of this macrocyclic diterpene. 
Several Euphorbia diterpenes have been proposed to circumvent MDR to 
enhance the efficacy of drugs. Among those, the jatrophane- and lathyrane-type 
macrocyclic diterpenes from Euphorbia species have been described as strong 
MDR-reversing compounds by the modulation of the P-gp protein (21). These 
promising findings led to the development in the in silico studies, as well as 
structure-activity relationship studies, to identify their pharmacophore structure and 
to optimize their efficacy. Findings indicate that P-gp inhibition contributes to the 
mechanisms of P-gp translocation, thereby enhancing the drug accumulation inside 
the cells. Therefore, the discovery of MDR modulators becomes a valuable 
therapeutic target for combating the progression of cancer diseases by enhancing the 
efficacy of anticancer agents and reducing the side effects that come with long 














2. The Justification and Significance of the Study 
 Natural products are continuously inspiring new drug targets and 
synthetic scaffolds. Between 1940 and 2010, a total of 175 small-molecule, anti-
cancer therapeutics have been accepted by the Food and Drug Administration. Of 
those 175 approved therapies, 49% were either discovered or derived directly from 
a natural product (23). Even with natural products providing such significant impacts 
towards the generation of new pharmaceuticals, there is still a growing demand for 
the discovery of new lead compounds. This cycle puts continuous pressure on 
finding novel compounds and sources for drug candidates.  
 
A- Silver maple (Acer saccharinum)  
The incidence of type 2, or non-insulin dependent, diabetes mellitus is 
increasing rapidly worldwide and has become a significant public health burden (24). 
Among various strategies used for type 2 diabetes management, clinical α-
glucosidase inhibitory drugs, such as acarbose, are used to block the activity of 
carbohydrate-hydrolyzing enzymes thus decreasing postprandial hyperglycemia (25).  
Over the past years, there has been renewed scientific attention in identifying 
natural plant-based α-glucosidase inhibitors for the treatment and management of 
diabetes. Therefore, silver maple has not been previously investigated for all of its 
polyphenolics content. Only two compounds were identified previously from silver 
maple which are Gramine and methyl-gallate (Fig. 11). As the total polyphenolic 
content level in silver maple leaves is high, it seems reasonable to investigate the 
chemical constituents in the leaves, which could also serve as α-glucosidase 
inhibitors. Therefore, a phytochemical study is proposed to isolate and identify 
known or undiscovered phenolic compounds from silver maple leaves and evaluate 
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these compounds for antioxidant and anti-diabetic activities. This study also 























Species: A. saccharinum 
Figure 11. Structures of chemical constituents previously identified in silver maple. 
 




B- Euphorbia saudiarabica. 
The importance of Euphorbia species has increased in the last five years, and 
the number of publications in this period has shown that this genus is producing a 
large number of promising bioactive compounds, mainly diterpenoids. Few of the 
Euphorbia species have been investigated thus far. In Saudi Arabia, for example, 
there are about 40 Euphorbia species, of which many are uninvestigated or poorly 
investigated; five of these are endemic, such as E. saudiarabica (26). Therefore, the 
Euphorbia saudiarabica species was chosen for investigation of its phytochemical 
and biological activities. 
Euphorbia saudiarabica was identified in 2007 and is endemic to the 
southwestern region of Saudi Arabia along the Albirk-Jazan road (Fig. 12) (27). It is 
a small tree that resembles as a candelabra-like succulent spiny shrub and does not 
exceed 3 meters in length. It produces a strong, white, skin-irritant latex. The aerial 
part of the plant was collected, dried, and extracted with methanol in order to screen 
their phytopharmacological properties. Approximately 123 g of methanolic extract 
was obtained from King Khalid University through a Materials Transfer Agreement 
with the University of Rhode Island. 
 
                                   A                                                                    B                               
Figure 12. (A) Map of Saudi Arabia (B) The aerial part of Euphorbia saudiarabica 
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3. The Objectives of the Study 
The objective of this study is to isolate and evaluate the phytochemical 
compositions and the pharmacological properties of two higher plants, silver maple 
(Acer saccharinum) and Euphorbia saudiarabica, through the following aims: 
 
• Aim 1 Phytochemical investigation of the silver maple leaves and the 
aerial part of Euphorbia saudiarabica using different isolation and 
purification processes, such as open column chromatography (OCC), thin 
layer chromatography (TLC), medium pressure liquid chromatography 
(MPLC), and high-performance liquid chromatography (HPLC), etc.  
 
• Aim 2 The pure compounds will be isolated, and then the structure of all 
compounds will be elucidated using several techniques, including IR, UV, 
HR-ESIMS, NMR, and experimental ECD. 
 
 
• Aim 3 Biological activities evaluation of all isolated phytochemicals will be 
conducted using different bioassays, such as cytotoxicity.  
 
• Aim 4 The flavonoids composition of Euphorbia saudiarabica crude extract 
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In the course of our group’s investigation of members of the maple (Acer) genus, a 
series of glucitol-core containing gallotannins (GCGs) were isolated and identified 
(by NMR and HREISMS). Among higher plants, only certain maple species are 
known to produce GCGs, compounds with potential nutraceutical and cosmetic 
applications due to their reported antioxidant, antidiabetic, anti-α-glucosidase, anti-
glycation, anticancer, and skin health promoting effects. Herein, we sought to 
investigate whether the previously un-investigated silver maple (Acer saccharinum) 
species was also a source of GCGs. Nine phenolic compounds, including six GCGs, 
were identified (by HPLC-DAD analyses using previously isolated standards) as 
ginnalins A-C (1-3), maplexins B, D, and F(4-6), methyl syringate (7), methyl 
gallate (8), and 3-methoxy-4-hydroxyphenol-1-β-D-(6 galloyl)-glucopyranoside (9). 
In addition, one sesquiterpenoid, namely, pubineroid A (10), was isolated and 
identified (by NMR). 
 













 The maple (Acer) genus contains thirteen species which are native to North America 
including the sugar (A. saccharum), red (A. rubrum), and silver (A. saccharinum) 
maples. Apart from sap which is primarily consumed as maple syrup [1], other maple 
plant parts (leaves, bark, etc.) have also been used as traditional medicines by the 
indigenous people of North America [2]. Our group has reported on the isolation and 
structure elucidation (by NMR and HREISMS) of over 70 phytochemicals, from the 
sugar, red, and sycamore (A. pseudoplatanus) maples [3-7]. Among these species, 
only the red maple yielded glucitol-core containing gallotannins (GCGs) [3, 4, 6]. 
These compounds have been reported, by our group [8-15], and others [16-20], to 
show a wide range of in vitro and in vivo biological effects including, antioxidant, 
anti-diabetic, anti-α-glucosidase, anti-glycation, anticancer, and skin-health 
promoting effects. Given the potential nutraceutical and cosmetic applications of 
these compounds, as well as our access to the aforementioned maple-derived 
phytochemical standards, herein, we sought to investigate whether the silver maple 
was a source of GCGs. Using authentic standards (previously isolated by our 
laboratory), nine phenolics, including six GCGs, were identified from silver maple 
leaves as ginnalins A-C (1-3), maplexins B, D, and F (4-6), methyl syringate (7), 
methyl gallate (8), and 3-methoxy-4-hydroxyphenol-1-β-D-(6-galloyl)-
glucopyranoside (9) (by HPLCDAD analyses, see Supplementary data, Table S1) 
[6, 7]. In addition, one sesquiterpenoid, namely, pubinernoid A (10), was isolated 
and identified (by NMR; see Supplementary data, Figures S1 and S2). Pubinernoid 
A was obtained as a white amorphous powder and its 1H and 13C NMR data were 
consistent with the literature [7]. The chemical structures of the compounds 
identified from silver maple leaves are shown in Figure 1. In summary, this is the 
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first reported phytochemical investigation of the silver maple which led to the 
identification of nine phenolic compounds (six GCGs and three phenolics) and a 
sesquiterpenoid.  Our findings add to the growing body of data of phytochemicals 
identified from the maple (Acer) genus, and more importantly, about which maple 
species produce GCGs, a promising class of bioactive plant polyphenols with 























General: High performance liquid chromatography (HPLC) analyses were 
performed on a Hitachi Elite LaChrom system consisting of a L-2130 pump, a L-
2200 autosampler, and a L-2455 Diode Array Detector. All 1H and 13C NMR 
spectra were acquired on a Bruker 300 MHz spectrometer using MeOD4 as solvent.  
Plant material: Silver maple (Acer saccharinum) leaves were collected on the 
Kingston campus of the University of Rhode Island (Kingston, RI, USA) in the 
summer of 2010 and were botanically authenticated by Mr. J. Peter Morgan. 
Voucher specimens (16JPM1-APS6310) are deposited in the Heber-Youngken 
Garden and Greenhouse at the College of Pharmacy, University of Rhode Island. 
Extraction of plant material: Air-dried silver maple leaves (1007.8 g) were 
macerated for 9 days with MeOH (5.5 L× 3). The filtrate was concentrated under 
reduced pressure to afford a dried methanol extract (250 g). This was suspended in 
distilled water and successively partitioned to yield n-hexanes (67.5 g), ethyl acetate 
(EtOAc; 28.7 g), and n-butanol (37.5 g) extracts after solvent removal in vacuo. The 
EtOAc extract, which contained the highest total polyphenol content (58.8% GAEs 
based on the Folin-Ciocalteau assay, see Supplementary data, Table S2), was 
selected for further phytochemical investigation (described below).   
 
Identification of compounds 1-9 in the EtOAc extract of silver maple leaves by 
HPLC-DAD analyses: The EtOAc extract (5 mg) was analyzed on a Phenomenex 
C18 column (250 × 4.6 mm, i.d. 5 μm). The injection volume was 10 μL and the 
flow rate was 0.75 mL/min. A gradient mobile phase solvent system consisting of 
solvent A (0.1% aqueous trifluoroacetic acid) and solvent B (MeOH) was used as 
follows: 0-50 min, 5%-46% B. The HPLC profile was monitored at 220 nm and 
26 
 
compounds 1-9 were identified by comparison of their retention times to authentic 
standards previously isolated by our laboratory from red maple [3, 4, 6].  
Isolation of compound 10 from the EtOAc extract of silver maple leaves: Having 
identified the major constituents in the EtOAc extract which were phenolics (1-9), 
we attempted to isolate the (minor) non-phenolic constituent/s (based on UV 
absorbance; see Supplementary Data, Table S1) present in the extract.  Briefly, the 
EtOAc extract (28.2 g) was purified on a silica gel column eluted with a gradient 
solvent system of chloroform/MeOH (50:1 - 1:1; v/v) to afford 11 fractions (F1 - 
F11). Fraction F3 (440 mg) was chromatographed on a Sephadex LH-60 column 
eluting with MeOH to afford 6 sub-fractions (13A - 13F). Fraction 13B (340 mg) 
was chromatographed on a silica gel column eluting with a gradient solvent system 
of hexane/dichloromethane (10:0 - 0:10; v/v) to afford 5 fractions (16A - 17C). 
Fraction 16C (15 mg) was further purified by C18 reversed-phase semi-preparative 
HPLC with a mobile phase consisting of MeOH and 0.1% aqueous trifluoroacetic 
acid (60:40; v/v) to afford compound 10 (3.4 mg, tR =12.2  min).  
 
Supplementary data: Supplementary data are available for this article and available 
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Methanol extracts of aerial parts of Euphorbia saudiarabica afforded five new 
macrocyclic-lathyrane diterpenoids, named saudiarabicain A–E (1–5). 1 and 2 
represent an unusual type of lathyrane diterpenoids. Structures of 1–5 were 
determined by analysis of extensive NMR and mass spectroscopic data, and the 
relative configuration of all compounds (1–5) were established by NOESY spectra 
analysis. Diterpenoid 2 showed a significant cytotoxicity effect against B16-
F10 murine melanoma cells, while the remaining compounds exhibited only 
moderate or no cytotoxicity activity against B16F10, human HaCat keratinocytes, 






















The Euphorbiaceae family is among the largest families of higher plants, 
composed of more than 300 genera and 7000 species subdivided into many 
subgenera and sections1. Among this family, the Euphorbia genus is one of the three 
largest genera of flowering plants, with approximately 2000 species2. The 
Euphorbia species all have milky irritant latex that is often rich in secondary 
metabolites; some of them are considered toxic. Several E. species have been used 
in ethnomedicine as purgatives and as treatments for asthma, tumors, and warts1. It 
is also well known for producing various types of secondary metabolites, primarily 
diterpenes, with immense chemical diversity3. Diterpenes occurring in the 
Euphorbia species are of considerable interest from the perspective of natural 
product drug discovery because of their wide range of unique biological activities 
and their high structural diversity.  
The importance of diterpenes from the Euphorbia genus is highlighted by the 
approval granted by the US Food and Drug Administration in 2012 for the treatment 
of actinic keratosis, a precancerous skin condition, for ingenol 3-angelate (ingenol 
mebulate, PEP005, Picato®, LEO pharma)4. Diterpenoids are the majority 
secondary metabolites of the Euphorbia genus with many different skeletons such 
as jatrophanes, ingenane, and lathyranes, as well as sesquiterpenoids, flavonoids, 
and steroids5. Previous publications on diterpenoids isolated from Euphorbia species  
have revealed novel compounds with promising cytotoxicity and multi-drug 
resistance (MDR) modularity effects, such as macrocyclic lathyrane and jatrophane 
diterpenes1. Also, several structure-activity relationship studies on Euphorbia 
species have revealed that the diterpenoids with the jatrophanes and lathyrane 
pharmacophore are very active MDR modulators due to the high conformational 
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flexibility of their 11, 12-membered rings6. 
Herein, we report the isolation and characterization of five new lathyrane-type 
diterpenoids named saudiarabicain A–E (1–5) from the aerial part of Euphorbia 
saudiarabica. E. saudiarabica is an endemic plant in Saudi Arabia and mainly 
distributed in the southwestern area of that country, close to the Red Sea. 
Furthermore, we evaluated the cytotoxicity effects of these compounds using three 
















RESULTS AND DISCUSSION 
 
Compound 1 was obtained as white amorphous powder and had molecular formula 
C31H40O11 as deduced by (+)-HRESIMS ion at m/z 633.2332 [M + Na]
+ (calcd 
633.2312). The 1H NMR and 13C NMR Data of compound 1 (Table 1) revealed 
three acetyl moieties and one benzoyl group (δC 170.5, 133.3, 129.5, 129.3, 128.5; 
δH 7.99, 7.55, 7.42). The remaining 20 carbons, building the lathyrane-type diterpene 
core structure, contained a rare oxymethine, four methyls, one cis C=C bond and one 
ketone carbonyl group7. . Their connections were deduced from correlations 
observed in the 1H-1H COSY and HMBC spectrum. Three spin systems were 
established by 1H-1H COSY correlations: H-1/H-2/H-3, 
H20/H13/H12/H11/H9/H8/H7 and H4'/H3' (Fig. 2A). The carbonyl group at C-14 
was determined by the long-range correlations of H-20 to C-14 and H-13 to C-14, 
which observed in the HMBC spectrum. The HMBC correlations of H-1 to C-4 and 
H-3 to C-15 supported the locations of the two oxygenated quaternary carbons: C-4 
and C-15. The assignment of the olefinic proton H-5 at δH 5.43 was determined by 
the HMBC correlation of H-5 to C-15. The HMBC correlations of H-19 to C-9, C-
12, and C-18, combined with the chemical shift of C-19 (103.1), supported the 
identification of the rare oxygenated C-19. The locations of the acetyl moieties were 
assigned by the HMBC correlations which showed in Fig. 2A. The planar structure 
of 1 was deduced as shown in Fig. 2A. The relative stereochemistry of 1 was 
assigned by NOESY correlations as shown in Fig. 2B. H-2, H-1α, H-3, H9, H-11, 
and H-19 were assigned randomly as α-oriented based on the NOESY correlations 
of H-2/H-1α, H-2/H-3, H-9/H-11, and H-11/H-19. Consequently, H-7, H-8, H-12, 
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and H-13 were assigned as β-oriented by NOESY correlations of H-7/H-8, H-8/H-
12, and H-12/H-13 (Fig. 2B). 
Compound 2 showed a (+)-HRESIMS [M + Na]+ ion peak at m/z 611.2495 (calcd 
for C33H38O11Na, 611.2468). Analysis of NMR spectra data suggested that the 
structure of compound 2 was closely related to compound 1 (Table. 1). The only 
major differences in the NMR data of compound 2 is the presence of angelate group 
signals instead of benzoyl group as it was in compound 1. (Fig. S1, supporting 
information).  
The HRESIMS of compound 3 showed a sodiated molecular ion at m/z 691.2751 
[M + Na] +, corresponding to the molecular formula of C36H44O12 (calcd, 691.2730). 
The 1H and 13C NMR data (Table 1) of 3 revealed the lack of chemical shift of C-
19 (103.1), which indicate that 3 is clearly different from 1 and 2. Analysis of 1H 
and 13C NMR revealed four acetoxy groups and one benzyl group (δc 170.5, 134.1, 
129.1, 128.2, 126.8, 40.7; δH 7.20, 3.65). The remaining 20 carbons, building the 
lathyrane-type diterpene core structure, contained one cis C=C and one ketone 
carbonyl group8. Their connections were deduced by 1H-1H COSY and HMBC 
spectra. Two spin systems were established by 1H-1H COSY correlations: H-1/H-
2/H-3 and H-20/H13/H-12/H-11/H-9/H-8/H-7 (Fig. 2C). The carbonyl group at C-
14 was determined by the long-range correlations of H-20 to C-14 and H-13 to C-
14, which was observed in the HMBC spectrum. The HMBC correlations of H-1 to 
C-4, H-3 to C-15 supported the locations of the two oxygenated quaternary carbons: 
C-4 and C-15. The olefinic proton H-5 at the δH 5.43 location was determined by the 
HMBC correlation of H-5 to C-15. The correlations of H-7 to phenylacetoxy 
carbonyl (δC 170.5) revealed that the phenylacetoxy group was located at C-7. The 
presence of acetoxy groups at C-3, C-8, C-12, and C-19 was suggested by HMBC 
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correlations between acetoxy carbonyls and H-3, H-8, H-12, and H-19, respectively. 
(Fig. 2C). The relative configuration of 3 was established by NOESY correlations. 
H-2, H-1α, H-3, H-9, H-11, and H-18 were assigned randomly as α-oriented on the 
basis of NOESY correlations of H-2/H-1α, H-2/H-3, H-9/H-11, and H-9/H-18. 
Consequently, H-7, H-8, H-12, and H-13 were assigned as β-oriented by NOESY 
interactions of H-7/H-8, H-8/H-12, and H-12/H-13 (Fig. 2D). 
Compound 4 was obtained as a white amorphous powder. The 1H NMR and 13C 
NMR data of 4 (Table 2) were quite similar to those of 3. Comparison between the 
1H NMR spectrum of 3 and 4 showed a difference only in the ester moieties. The 1H 
NMR and 13C NMR spectrum of 4 revealed the presence of one benzoyloxy group, 
one angelate group, two acetoxy groups, and a free hydroxyl. In the HMBC 
spectrum, the carbonyls of the benzoyloxy, one angelate group, and two acetoxy 
groups displayed cross-peaks with H-8, H-7, H-12, and H-19, indicating the groups 
located at C-8, C-7, C-12, and C-19, respectively. The free hydroxyl was located at 
C-3 because of the HMBC correlation between the free hydroxyl and C-3. By 
comparing the NMR data of 5 (Table 2) with those of 4, we deduced the structure 
of 5, which is the same as that of compound 4 except for the benzoyloxy group at C-





























                         
Figure 2. (A and C) Key HMBC and COSY (bold bonds) for compound 1 and 3, respectively. (B 









Table 1. 1H NMR and 13C NMR data (300 and 75 MHz, CD3OD) for compounds 1–3 
  1  2  3 
no. δH (J in Hz) δC  δH (J in Hz) δC  δH (J in Hz) δC 
1α 2.56 dd (15.0, 9.0) 34.1  2.59 dd (14.7, 9.0)  34.1  2.70 dd (14.7, 9.0)  31.1 
1β 1.67 d (15.0)    1.72 d (15.0)    1.60 d (14.7)  
2 2.34 m 29.2  2.36 m 29.3  2.41 m 29.3 
3 5.03 d (8.4) 77.1  5.06 d (8.4) 77.1  5.13 d (8.7) 76.8 
4  73.3   73.3   71.0 
5 5.70 s 116.7  5.53 s 116.4  5.43 m 117.6 
6  142.1   142.4   138.7 
7 5.45 brs 77.2  5.22 brs 77.1  5.04 d (1.8) 76.4 
8 5.02 dd (11.2, 1.2) 70.2  4.92 d (11.1) 70.2  4.54 dd (10.8, 1.8) 70.7 
9 1.61 dd (10.8, 9.0) 27.2  1.46 dd (10.8, 9.0) 27.2  1.30 dd (10.8, 9.0) 25.0 
10  33.0   32.7   21.6 
11 1.34 dd (8.7, 1.5) 31.0  1.25 m 30.9  1.15 dd (11.1, 9.0) 30.9 
12 4.65 dd (4.5, 1.5) 78.1  4.58 d (4.8) 78.0  4.84 dd (11.1, 7.8) 69.4 
13 3.34 qd (6.6, 4.5) 48.7  3.30 qd (6.9, 5.1) 48.7  2.82 dq (7.5, 7.2) 43.0 
14  206.4   206.4   207.0 
15  72.9   72.9   73.4 
16 0.84 d (7.2) 16.0  0.84 d (7.5) 16.0  0.84 d (7.5) 15.9 
17 2.08 s 16.6  1.97 d (1.8) 16.5  1.96 d (1.5) 16.2 
18 1.25 s 17.0  1.20 s 17.0  1.00 s 23.2 
19 6.13 s 103.1  6.03 s 103.0  19α: 4.01 d (12.0)  64.7 
       19β: 3.46 d (12.0)  
20 0.96 d (6.6) 6.8  0.93 d 6.6 6.8  0.92 d (7.2) 12.4 
3-OAc  170.5   170.5   170.6 
 1.99 s 19.1  1.97 s 19.0  2.00 s 19.7 
8-OAc  170.6   170.7   170.4 
 1.87 s 19.5  1.98 s 19.9  1.94 s 19.0 
12-OAc        170.8 
       1.89 s 19.33 
19-OAc  170.8   170.6   171.3 
 2.01 s 19.9  1.84 s 19.5  1.88 s 19.5 
7-R  O-Bz   
O-
Ang 
  O-Bzl 
C=O  170.5   166.5   170.5 
1'  129.5      134.1 
2' 7.99 m 129.3   128.0   129.1 
3' 7.42 ddd (7.2, 7.2, 1) 128.5  6.86 q (6.6)  138.4  7.20 5H m 126.8 
4' 
7.55 dddd (7.5, 7.5, 
1.5, 1.5) 
133.3  1.74 d (6.6) 13.2   128.2 
5' 7.42 ddd (7.2, 7.2, 1.5) 128.5  1.76 s 10.8   126.8 
6' 7.99 m 129.3  - -   129.1 







Table 2. 1H NMR and 13C NMR data (500 and 125 MHz) for compounds 4–5 (4 in DMSO-d6, 5 in CD3OD). 
  4   5   
no. δH (J in Hz) δC   δH (J in Hz) δC   
1α 2.03 dd (13.5, 10.5) 32.6  2.19, m 31.8  
  
1β 1.85 d (14.0) 
  1.90, m   
2 1.84 m 33.2  1.90 m 33.0  
3 3.83 dd (6.5, 5.5)  75.2  3.90 d (5.0) 75.7  
4  73.3   73.2  
5 6.11 q (1.5) 118.4  6.16 s 117.8  
6  136.2   136.8  
7 5.43 d (1.5) 75.9  5.29 d (1.5) 76.2  
8 5.14 dd (11.0, 2.0) 72.5  4.82 dd (11.0, 1.5) 70.9  
9 1.65 m  25.5  1.64 dd (11.0, 9.0) 25.6  
10  21.7   21.6  
11 1.37 dd (11.5, 9.0) 31.6  1.42 dd (11.0, 9.0) 31.3  
12 5.08 dd (11.5, 3.5) 69.5  5.01 dd (11.5, 3.5) 69.5  
13 2.94 qd (7.0, 3.5) 43.4  3.04 qd (7.0, 3.5) 43.2  
14  207.8   207.8  
15  73.2   73.0  
16 0.88 d (7.0) 13.0  0.99 d (6.5) 11.0  
17 2.11 d (1.5) 17.7  2.13 s 16.4  
18 1.16 s 24.4  1.16 s 23.2  
19α 3.88 d (12.0) 64.9  4.08 d (12.0) 64.8  
19β 3.62 d (12.0)   3.60 d (12.0)   
20 0.95 d (7.0) 13.4  1.04 d (7.0) 12.3  
3-
OAc 
3-OH: 5.32 d (6.5)      
       
12-
OAc 
 170.3   170.8  
 2.03 s 21.3  2.10 s 19.7  
19- 
OAc 
 170.5   171.2  







C=O  166.3   166.6  
1'       
2'  128.2   128.1  
3' 6.89 q (7.0) 139.0  6.95 m 138.3  
4' 1.79 d (7.0) 14.8   1.84 d (7.0) 13.1  
5' 1.78 s 12.5  1.87 s 10.8  
6' - -   - -   




C=O   165.2   166.9  
1''  129.8     
2'' 7.87 dd (7.5, 1.5) 129.6   128.0  
3'' 7.53 dd (7.5, 7.5) 129.4  6.83 m 138.3  
4'' 7.66 m 134.0  1.81 d (7.5) 13.1  
5'' 7.53 dd (7.5, 7.5) 129.4  1.80 s 10.6  




All compounds (1–5) were evaluated for cytotoxicity in three cell lines. B16F10 
murine melanoma cells are often used for their high metastatic potential and 
moreover their ability to express MDR19. Similarly, HaCat, a line of immortalized 
human keratinocytes, were used to model one of the outermost layers of skin and 
thus serve as a significant site of action for this Euphorbia spp. based terpenoids10. 
Cell Titer Glo is a luminescence-based viability assay that utilizes luciferase and 
ATP from lysed cells to generate a positive correlation between viability and 
luminesce intensity. Viable cells which produce ATP will produce a higher 
luminescence signal as opposed to damaged (necrotic) or dying (apoptotic) cells11. 
As a cytotoxic control, etoposide, an MDR1 substrate and chemotherapeutic agent12, 
at 50 μM decreased B16F10 cell viability by 25.16%. Only compounds 2, 3, and 4 
induced significant toxicity. Moreover, compound 2 had the greatest range of 
toxicity from 100 μM (49.63% decrease) to 20 μM (14.69% decrease). In human 
keratinocytes (HaCat), each compound caused a decrease in cell viability above 40 
μM. Compounds 3 and 4 caused reductions in cell viability by approximately 
12.42% and 17.92%, respectively, at a concentration of 30 μM. Compound 3 was 
able to decrease viability by as much as 93.63% at 50 μM. SH-SY5Y cells are 
typically used in neuropharmacology and neurodegenerative studies to model the 
sensitive nature of neurons13. Specifically, undifferentiated SH-SY5Y cells serve as 
an in vitro model for cancer and Parkinson’s disease due the dopaminergic receptors 
available13. Exposure to etoposide at 10 μM decreased viability by approximately 
44.64% (as in agreement with literature14). The compounds induced a cytotoxic 


















General Experimental Procedures. The general experiments were completed 
according to the reported procedures with minor modification (General 
Experimental Procedures, Supporting Information). 
Plant Material. Aerial parts of E. saudiarabica were collected in July 2015 in 
Thahban, Asir Province, Saudi Arabia. A.A. Fayed and D.A. Al-zahrani identified 
the plant species in 200715. 
Extraction and Isolation. Air-dried powder of E. saudiarabica was macerated with 
methanol (3 × 15 L). The filtrate was concentrated under reduced pressure to afford 
a dried methanol extract (135 g). This was suspended in distilled water and 
successively partitioned to yield n-hexanes (66.6 g), ethyl acetate (3.32 g), and n-
butanol (13.88 g) extracts after solvent removal in vacuo. The n-hexanes extract was 
dissolved in acetonitrile and successively partitioned again with n-hexanes to yield 
acetonitrile extract (22.1 g). Next, acetonitrile extract was fractioned using silica gel 
column eluted with n-hexanes/EtOAc (from 20:1 to 3:1) and then with 
CHCl3/MeOH (from 40:1 to 1:1) to afford six major fractions (ES5–ES10). Fraction 
ES8 (1.07 g) was fractionated by semi-preparative HPLC (CH3CN/H2O) to afford 
two major fractions (ES8A and ES8B). Fraction ES8A (100 mg) was further purified 
by C18 reversed-phase semi-preparative HPLC (CH3CN/H2O) to give compound 1 
(19.1 mg). Fraction ES6 (1.28 g) was chromatographed over MCI gel column 
chromatography eluting with H2O/MeOH (9:1 to 1:9) to afford four major fractions 
(ES6A–ES6D). Fraction ES6C was purified by semi-preparative HPLC 
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(CH3CN/H2O 45:55, 2.5 mL/min) to obtain compounds 2 (6.2 mg) and 3 (5.5 mg). 
Fraction ES9 (1.3 g) afforded compounds 4 (3.5 mg) and 5 (2.6 mg) by repeated 
semi-preparative HPLC (CH3CN/H2O 35:65, 2.5 mL/min). 
Saudiarabicain A (1) Reddish amorphous powder; [α]
20 
D  +78 (c 0.5, MeOH); 
UV (MeOH) max (log ε) 208 (5.61), 272 (4.75) nm; IR (KBr) max 2965, 1732, 1271, 
1235, 1023, 989 cm−1; 1H and 13C NMR (CD3OD), see Table 1; (+)-HRESIMS m/z  
633.2332 [M + Na]+ (calcd for C33H38O11Na, 633.2312).  
Saudiarabicain B (2) White amorphous powder; [α]
20 
D  +78 (c 0.5, MeOH); 
UV (MeOH) max (log ε) 203 (5.40), 270 (3.49) nm; IR (KBr) max 1737, 1716, 1234, 
1012, 988 cm−1; 1H and 13C NMR (CD3OD), see Table 1; (+)-HRESIMS m/z 
611.2495 [M + Na]+ (calcd for C31H40O11Na, 611.2468).  
Saudiarabicain C (3) White amorphous powder; [α]
20 
D  +78 (c 0.5, MeOH); 
UV (MeOH) max (log ε) 210 (4.93), 270 (3.71) nm; IR (KBr) max 2965, 1732, 1245 
cm−1; 1H and 13C NMR (CD3OD), see Table 1; (+)-HRESIMS m/z 691.2751 [M + 
Na]+ (calcd for C36H44O12Na, 691.2730).  
Saudiarabicain D (4) White amorphous powder; [α]
20 
D  +78 (c 0.5, MeOH); 
UV (MeOH) max (log ε) 200 (4.56), 270 (3.20) nm; IR (KBr) max 1716, 1299, 1243, 
1180 cm−1; 1H and 13C NMR (DMSO-d6), Table 2; (+)-HRESIMS m/z 675.2785 [M 
+ Na]+ (calcd for C36H44O11Na, 675.2781).  
Saudiarabicain E (5) White amorphous powder; [α]
20 
D  +78 (c 0.5, MeOH); 
UV (MeOH) max (log ε) 222 (3.92), 275 (2.84) nm; IR (KBr) max 2958, 1344, 
1241,1135 cm−1; 1H and 13C NMR (CD3OD), see Table 2; (+)-HRESIMS m/z 




Murine B16F10 melanoma cells and human HaCat keratinocytes were generously 
donated by Dr. Wen of Providence College. Human SH-SY5Y neuroblastoma cells 
were obtained from the European Collection of Authenticated Cell Cultures 
(ECACC; Porton Down, England UK). Melanoma cells and keratinocytes were 
maintained using DMEM supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomyces antibiotic cocktail. Neuroblastoma cells were maintained 
using DMEM/F12, also supplemented with 10% FBS and 1% pen/strep antibiotic 
cocktail. All cells were housed in a humidified incubator set to 37 °C under 5% CO2. 
Cells were counted prior to seeded onto assay plates by using a hemocytometer and 
trypan blue dye. Following seeding, cells were allowed to incubate for at least 24 
hours in serum-free media. Compounds were dissolved in DMSO (Sigma Aldrich, 
St. Louis, MO, USA) and diluted into serum-free media whereby the final DMSO 
content was less than 0.1% DMSO.  
Cell Viability Assessment 
Cell viability was determined using Cell Titer Glo 2.0 luminescence-based assay 
(Promega, Madison, WI, USA). As previously reported by our group16, cells were 
seeded on white-walled 96-well plates at a density of either 100,000 cells/mL 
(B16F10 and SH-SY5Y) or 200,000 cells/mL (HaCat) to yield an 85% confluent 
plate following 24 hours. In brief, cells were treated with test compounds at 100, 50, 
40, 30, 20, and 10 μM for 24 hours. Cell Titer Glo Reagent was then added directly 
to each well, mixed on an orbital shaker for approximately 2 minutes, and allowed 
to incubate at room temperature for 10 minutes prior to measuring luminescence 




Data are reported as mean ± standard error where each experiment was performed 
in triplicate. Statistical analysis was performed using Graphpad Prism Software (La 
Jolla, CA, USA) and significance was determined using one-way analysis of 
variance (ANOVA) using Dunnett’s Correction for multiple comparisons. 
Calculated P values were determined to be as follows: P< 0.05*, P< 0.01**, 
P<0.001***, P<0.0001****. 
ASSOCIATED CONTENT 
Supporting Information: The Supporting Information is available free of charge 
on the ACS Publications website…. 
AUTHOR INFORMATION 
Corresponding Author 
(N.P.S.) Phone: +1 401-874-9367; Fax: 401-874-5787; Email: nseeram@uri.edu 
ORCID 
Navindra Seeram: 0000-0001-7064-2904 
Author Contributions 
§ Abdullatif Bin Muhsinah and Yongqiang Liu contributed equally to this work.  
Notes: The authors declare no competing financial interest. 
ACKNOWLEDGEMENTS 
Research reported in this publication was made possible by the use of equipment 
and services available through the RI-INBRE Centralized Research Core Facility 
which is supported by the Institutional Development Award (IDeA) Network for 
Biomedical Research Excellence from the National Institute of General Medical 




(1) Vasas, A.; Hohmann, J. J. Chem. Rev. 2014, 114, 8579–8612 
(2) Ernst, M.; Saslis-Lagoudakis, C. H.; Grace, O. M.; Nilsson, N.; Simonsen, 
H. T.; Horn, J. W.; Rønsted, N. Scientific Reports. 2016, 6: 30531.  
(3) Ramsay, J. R.; Suhrbier, A.; Aylward, J. H.; Ogbourne, S.; Cozzi, S. J.; 
Poulsen, M. G.; Baumann, K. C.; Welburn, P., Redlich, G. L., Parsons, P. 
G. Br. J. Dermatol. 2011, 164: 633. 
(4) Lebwohl, M.; Swanson, N.; Anderson, L. L.; Melgaard, A.; Xu, Z.; Berman, 
B. N Engl J Med. 2012, 366: 1010–1019.  
(5) Shi, Q.-W.; Su, Z.-H.; Kiyota, H. Chemical Reviews. 2008, 108 (10), 4295–
4327. 
(6) Corea, G.; Fattorusso, E.; Lanzotti, V.; Motti, R.; Simon, P. N.; Dumontet, 
C.; Di Pietro, A. J. Med. Chem. 2004, 47, 988–992. 
(7) Fakunle, C. O.; Okogun, J. I., Ekong, D. E.; Connolly, J. D., Rycroft, D. S. 
J. Chem. Soc., Perkin Trans. 1. 1990, 0, 727–730. 
(8) Fatope, M. O.; Zeng, L.; Ohayagha, J. E.; McLaughlin, J. L. Bioorg.Med. 
Chem. Lett. 1996, 4, 1679. 
(9) He, X.; Wang, J.; Dou, J.; Yu, F.; Cai, K.; Li, X.; Gu, N. Experimental and 
therapeutic medicine. 2011, 2(5), 911–916. 
(10) Chudzik, M.; Korzonek-Szlacheta, I.; Król, W. Molecules. 2015, 20(1), 
1610–1625. 
(11) Crouch, S. P., Kozlowski, R., Slater, K. J., and Fletcher, J. J. Immunol. 
Methods. 1993, 160, 81–88. 
(12) Krishna, R.; Mayer, L. D. European Journal of Pharmaceutical Sciences. 
2000, 11(4), 265–283. 
48 
 
(13) Xicoy, H.; Wieringa, B.; Martens, G. J. Molecular Neurodegeneration. 
2017,12(1),10. 
(14) Cui, H., Schroering, A.; Ding, H. F. Molecular Cancer Therapeutics. 
2002, 1(9), 679–686. 
(15) Fayed, A., Al-Zahrani, A. Edinburgh J. of Bot. 2007, 64(2): 117–129. 
(16) Ma, H., DaSilva, N. A., Liu, W., Nahar, P. P., Wei, Z., Liu, Y.; Shaikh, Z. 












































Liquid Chromatography Coupled with Time-of-Flight Mass Spectrometry for 
Rapid Identification of Flavonoids from Aerial Parts of Euphorbia 
saudiarabica 
Abdullatif Bin Muhsinah§, Chunting Li§, Navindra Seeram* 
 
Bioactive Botanical Research Laboratory, Department of Biomedical and 
Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 
Kingston, RI 02881, USA 
 
§ Abdullatif Bin Muhsinah and Chunting Li contributed equally to this work.  
* Correspondence should be addressed to: 
Navindra P. Seeram  
Bioactive Botanical Research Laboratory, Department of Biomedical and 
Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 
Greenhouse Road, Kingston, RI 02881, USA  
Tel: +1 401-874-9367; Fax: +1 401-874-5787; Email: nseeram@uri.edu 
 
KEYWORDS:  
Euphorbia saudiarabica, flavonoids, Tandem mass spectrometry 
 
 





The dried methanolic extract of aerial parts of Euphorbia saudiarabica was 
subjected to investigate its flavonoid composition using LC-ESI-TOF-MS/MS. In 
the present study, 36 flavonoids were identified. The compounds constituted 7 
flavonoids based on the galangin aglycon, 9 flavonoids based on the apigenin 
aglycon, and 20 flavonoids originated from luteolin. Among these, 3 compounds are 
















Flavonoids and their conjugate forms are some of the most abundant 
polyphenols, and more than 8000 different flavonoids have been demonstrated so 
far. These flavonoids are considered to be the most plentiful natural products in the 
human diet since they are found in many plant tissues, including fruits and 
vegetables. In addition, the presence of flavonoids among plant genera, such as 
Euphorbia genus, are widely described. A literature review of the Euphorbia genus 
showed that many of its secondary metabolites, like diterpenoids and flavonoids, are 
highly bioactive [1]. Euphorbia saudiarabica is one of about 8000 species of the 
family Euphorbiaceae [2]. It is an endemic species to the southwest of Saudi Arabia 
close to the Red Sea [3]. This plant, like other Euphorbia species, is known for its a 
milky skin-irritant latex.  
To our knowledge, the flavonoid content of E. saudiarabica have not been 
studied. Therefore, the objective of the present study was to determine the 
phytochemical profiles of the total flavonoid contents of this plant using the liquid 









MATERIALS AND METHODS 
Chemicals 
LC-MS grade methanol was purchased from Sigma-Aldrich (St. Louis, MO, USA).  
 
Sample preparation 
Air-dried powder of E. saudiarabica (1 g) was macerated with methanol (3 × 15 
mL). The filtrate was concentrated under reduced pressure to afford a dried methanol 
extract. The methanol extract was re-dissolved in 10 mL acetonitrile, then 
partitioned with hexane (3 × 10 mL). The acetonitrile layer was concentrated under 
reduced pressure and re-dissolved in methanol. The methanol solution was stored at 
−20 °C and filtered (0.22 μm) before analysis. 
 
Liquid Chromatography-Mass Spectrometry Conditions 
LC-ESI-TOF-MS/MS analyses were performed on a SHIMADZU Prominence 
UFLC system (Marlborough, MA, USA) consisting of two LC-20AD pumps, a 
DGU-20A degassing unit, a SIL-20AC auto sampler, a CTO-20AC column oven, 
and a CBM-20A communication bus module. Chromatographic separation was 
performed on a 150 mm × 4.6 mm i.d., 3 μm, Atlantis dC18 column (Waters, 
Milford, MA, USA). The mobile phase consisted of 0.1% formic acid/methanol (A) 
and 0.1% aqueous formic acid (B) with a gradient elution of 5% A from 0 to 5 min, 
5%–95% A from 5 to 95 min. The column temperature was 40 °C, the flow rate was 
0.50 mL/min, and the injection volume was 10 μL. Mass spectrometry was 
performed using a Triple TOF 4600 system from Applied Biosystems/MDS Sciex 
(Framingham, MA, USA) coupled with ESI interface. Nitrogen was used in all 
cases. In this study, the parameters were optimized as follows: ESI voltage, −4500 
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V; GS1, 40 psi; GS2, 55 psi; CUR, 30 psi; turbo gas temperature, 550 °C; 
declustering potential, −80 V; collision energy, 40 eV. Instrument calibration was 
carried out according to the manufacturer’s instructions. The mass range was set 


















RESULTS AND DISCUSSION 
Qualitative characterization of the flavonoids present in the methanol extract of 
aerial parts of E. saudiarabica was performed in ESI negative ionization mode, and 
all of the compounds showed [M − H]– ions (Table 1). Accurate mass data were then 
acquired in full scan analysis, and product ion mass data were acquired via the 
information dependent acquisition (IDA) method. An Atlantis dC18 column was 
used, and formic acid was introduced into the mobile phase (0.1%) to alleviate peak 
tailing and to produce better peak shapes. The acidic conditions did not significantly 
affect the ionization efficiency of the compounds in negative mode.  
In the present study, 36 flavonoids were identified based on previously reported 
MS/MS fragmentation patterns for flavonoids [4]. The compounds constituted 7 
flavonoids based on the galangin aglycon, 9 flavonoids based on the apigenin 
aglycon, and 20 flavonoids originated from luteolin (Table 1). Among these, 3 
compounds are malonyl substituted, and 13 compounds are acetyl substituted. The 
total ion chromatograms profiles of the compounds are shown in Figure. 1. Accurate 
mass measurements, retention times (tR), formula, errors, and main MS/MS product 

























Table 1. LC-ESI-TOF-MS/MS data for flavonoids identified in a methanol extract 









Major and important MS/MS 
ions  
Identification 
1 41.27 C33H38O21 769.1844 1.4528 607, 431, 337, 311, 269, 175, 
151, 149, 113 
A-(GlcUA-Hex, 
Hex) 
2 45.15 C28H30O16 609.1460 -0.1789 447, 285, 199, 175, 151, 133 L-(Hex, Hex) 
3 46.95 C27H28O17 623.1272 2.9311 605, 561, 447, 357, 337, 327, 
285, 199, 175, 151, 133 
L-(Hex, GlcUA) 
4 47.53 C28H30O16 609.1487 4.2535 447, 285, 199, 175, 151, 133 L-(Hex-Hex) 
5 48.32 C27H28O17 623.1273 3.0916 447, 285, 199, 175, 151, 133 L-(Hex-GlcUA) 
6 48.67 C28H30O16 609.1476 2.4477 447, 357, 327, 285, 199, 175, 
151, 133 
L-(Hex-Hex) 
7 50.12 C27H28O16 607.1313 1.3853 431, 337, 315,  269, 225, 151, 
149,  117, 113, 107 
A-(Hex-GlcUA) 
8 51.18 C21H20O11 447.0942 2.0457 357, 327, 285,  199, 175, 151, 
133 
L-Hex 
9 51.47 C28H30O17 637.1434 3.7297 619, 461, 337, 299, 284, 199, 
175, 151, 133 
ML-(Hex-
GlcUA) 
10 51.77 C28H30O16 609.1487 4.2535 447, 285, 199, 175, 151, 133 L-(Hex-Hex) 
11 51.86 C27H30O15 593.1525 2.2012 431, 269, 225, 151, 149,  117, 
113, 107 
A-(Hex-Hex) 




13 52.25 C27H28O16 607.1312 1.2206 431, 357, 337,  269, 225, 151, 
149,  117, 113, 107 
A-(Hex-GlcUA) 




15 54.03 C28H30O16 621.1471 0.991 431, 269,  225, 201, 183, 181, 
151, 149, 117, 113 
A-(Hex-
MethylGlcUA) 
16 54.07 C24H22O14 533.0937 0.0386 489, 285, 199, 175, 151, 133 L-(6-
malonylHex) 
17 54.20 C30H30O20 709.1279 3.0071 665, 623, 603, 489, 447, 379, 
357, 285, 199, 175, 151, 133 
L-(malonylHex, 
GlcUA) 
18 54.36 C23H22O12 489.1058 3.9866 447, 429, 357, 327, 285, 256, 
227, 199, 175, 151, 133 
L-acetylHex 
19 54.72 C21H20O10 431.0976 -1.7878 269, 268, 240, 211, 151, 117 G-3-O-Hex 
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20 56.02 C21H20O10 431.0990 1.4596 269, 268, 240, 211, 151, 117 G-3-O-Hex 
21 56.41 C21H20O11 447.0934 0.2563 285, 199, 175, 151, 133 L-Hex 
22 56.96 C24H22O14 533.0949 2.2896 489, 447, 285, 199, 175, 151, 
133 
L-malonylHex 
23 56.99 C23H22O12 489.1041 0.5109 447, 357, 327, 285, 256, 227, 
199, 175, 151, 133 
L-acetylHex 




25 57.70 C23H22O11 473.1095 1.1932 269, 268, 240, 211, 151, 117 G-3-O-acetylHex 
26 58.38 C23H22O11 473.1088 -0.2863 269, 268, 240, 211, 151, 117 G-3-O-acetylHex 
27 58.59 C21H20O11 447.0937 0.9273 285, 199, 175, 151, 133 L-Hex 
28 59.02 C23H22O11 473.1092 0.5591 269, 268, 240, 211, 151, 117 G-3-O-acetylHex 




30 60.47 C23H22O11 473.1096 1.4046 269, 268, 240, 211, 151, 117 G-3-O-acetylHex 
31 61.79 C23H22O12 489.1044 1.1243 447, 357, 327, 285, 256, 227, 
199, 175, 151, 133 
L-acetylHex 




33 63.10 C15H10O6 285.0401 -1.2692 199, 175, 151, 133 L 
34 64.42 C23H22O12 489.1044 1.1243 285, 199, 175, 151, 133 L-(6-acetylHex) 
35 65.25 C23H22O11 473.1096 1.4046 269, 268, 240, 211, 151, 117 G-3-O-acetylHex 
36 67.36 C15H10O5 269.0460 1.6832 227, 225, 201, 197, 183, 181, 













Compounds 19 (tR=54.72 min) and 20 (tR=56.02 min) displayed same [M − H]
− 
at m/z 431, and their MS/MS fragmentation all yielded the aglycone Y0
− ion at m/z 
269. This aglycone was further confirmed as galangin by the characteristic product 
ions at m/z 117, 151, 211, and 240 [4]. The product ion at m/z 269 [M − H − 162]− 
also indicated the loss of a hexose group (162 Da). However, the nature of hexose 
could not be determined only by MS data. Therefore, compounds 19 and 20 were 
identified as galangin-O-hexosides. In their MS/MS spectrum, [Y0 − H]
− ion at m/z 
268 with high intensity was also observed. Flavonols substituted at the 3-OH 
position should yield a high-intensity fragment [Y0 − H]
−, sometimes higher than the 
Y0
− ion [5]. Thus, the glycosylation position of compounds 19 and 20 should be at 
3-OH. Therefore, compound 19 and 20 were further identified as galangin-3-O-
hexosides.  
Compounds 25, 26, 28, 30 and 35 all produced the same [M − H]− ion at m/z 
473 with different tR of 57.70, 58.38, 59.02, 60.47, and 65.25 min, respectively. In 
their MS/MS spectra, they all showed the same fragment ion at m/z 269 which was 
produced by the loss of an acetyl-hexose group (204 Da). Also, the characteristic 
fragment ions of galangin at m/z 117, 151, 211, and 240 were observed. Thus, these 
compounds were identified as galangin-O-(acetyl-hexoside). High-intensity radical 
aglycone [Y0 − H]
− ion at m/z 268 was found in the MS/MS spectra of all compounds, 
indicating that they were galangin-3-O-(acetyl-hexoside). 
Compound 36 (tR=67.36 min) produced the [M − H]
− ions at m/z 269. In the 
MS/MS spectrum, the typical product ions at m/z 107, 117, 149, 151, and 225 led to 
the identification of compound 36 as apigenin [6]. Compound 11 (tR=51.86 min) 
displayed a pseudomolecule ion [M − H]− at m/z 593 and gave the aglycone Y0
− ion 
at m/z 269 in its MS/MS spectrum. The typical product ions at m/z 107, 117, 149, 
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151, and 225 led to the identification of the aglycone as apigenin. The loss of 324 
Da could be attributed to the loss of a caffeoyl-hexose unit or a di-hexose unit. It 
should be noted that deprotonated apigenin-O-caffeoylhexoside possesses the same 
nominal molecular weight of 593 as deprotonated apigenin-O-hexosylhexoside, but 
their accurate molecular weights are different, i.e., 593.1300 for apigenin-O-
caffeoylhexoside and 593.1511 for apigenin-O-hexosylhexoside, and their 
molecular formulae are C30H26O13 and C27H30O15, respectively. According to the 
deprotonated molecular ion [M − H]− at m/z 593.1525 measured by TOF-MS, 
compound 11 was identified as apigenin-O-hexosylhexoside. 
Compounds 7 (tR=50.12 min) and 13 (tR=52.25 min) produced the same [M − 
H]− ions at m/z 607. In their MS/MS spectra, they showed a same aglycone Y0
− ion 
at m/z 269. In addition, the aglycone was determined as apigenin by the characteristic 
fragment ions at m/z 107, 117, 149, 151, and 225. A weak ion at m/z 431 arising from 
the loss of 176 Da was also observed in their MS/MS spectrum, which represents a 
loss of a glycuronic acid unit. Further loss of 162 Da ([M − H − glycuronic acid unit 
− hexose unit]−) allowed us to infer that compounds 7 and 13 may consist of the 
apigenin moiety with a glycuronic acid group (176 Da) and a hexose group (162 
Da), while the glycuronic acid group is in the external position. Thus, compounds 7 
and 13 were identified as apigenin-O-hexosylglycuronides. 
Compounds 14 (tR=52.67 min), 24 (tR=57.15 min), and 32 (62.20 min) all 
produced the same [M − H]− ions at m/z 649. In their MS2 spectra, they all showed 
the same aglycone Y0
− ions at m/z 269. In addition, the characteristic fragment ions 
of apigenin at m/z 107, 117, 149, 151, and 225 were observed. The weak ions at m/z 
473 in their MS/MS spectrum indicated that compounds 14, 24, and 32 contained a 
glycuronic acid group (176 Da) and an acetyl-hexose group (204 Da), while the 
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glycuronic acid group is in the external position. Thus, compounds 14, 24, and 32 
were identified as apigenin-O-acetylhexosylglycuronides. 
Compounds 15 (tR=54.03 min) displayed its [M − H]
− ions at m/z 621. In the 
MS/MS spectra, the aglycone Y0
− ion at m/z 269 was observed and was identified as 
apigenin by the characteristic fragment ions at m/z 107, 117, 149, 151, and 225. A 
weak ion at m/z 431 indicated a loss of a methyl-glycuronic acid unit (190 Da). 
Compound 15 was identified as apigenin-O-(hexosyl-methylglycuronide). 
Compounds 1 (tR=41.27 min) produced the [M − H]
− ions at m/z 769. In the 
MS/MS spectra, it gave the aglycone Y0
− ion at m/z 269. In addition, the aglycone 
was determined as apigenin by the characteristic fragment ions at m/z 107, 117, 149, 
151, and 225. The loss of 500 Da allowed us to infer that compound 1 may consist 
of the apigenin moiety with a glycuronic acid group (176 Da) and two hexose groups 
(162 Da). The high-intensity ion at m/z 431 indicated a hexose group and a hexose-
glycuronic acid group glycosylated to two different positions on the apigenin moiety 
of compound 1. The weak ions at m/z 607 arising from the loss of 162 Da was also 
observed in MS/MS spectrum, which represents the hexose as in the external 
position of the hexose-glycuronic acid group. Thus, compound 1 was identified as 
apigenin-O-(hexoside, glucuronylhexoside). 
Compound 33 (tR=63.10 min) produced the [M − H]
− ions at m/z 285. In the 
MS/MS sepectrum, the typical product ions at m/z 133, 151, 175, and 199 led to the 
identification of compound 33 was luteolin [4]. Compounds 8 (tR=51.18 min), 21 
(tR=56.41 min), and (27) (tR=58.59 min) displayed the same [M − H]
− ions at m/z 
447, and their MS/MS spectrum all yielded the aglycone Y0
− ion at m/z 285. This 
aglycone was further confirmed as luteolin by the characteristic product ions at m/z 
133, 151, 175, and 199. The product ion at m/z 285 [M − H − 162]− also indicated 
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the loss of a hexose group (162 Da). Therefore, compounds 8, 21, and 27 were 
identified as luteolin-O-hexosides.  
Compounds 18 (tR=54.36 min), 23 (tR=56.99 min), 31 (tR=61.79 min), and 34 
(tR=64.42 min) all produced the same [M − H]
− ions at m/z 489. In their MS/MS 
spectra, they all showed the same aglycone Y0
− ions at m/z 285. In addition, the 
characteristic fragment ions of luteolin at m/z 133, 151, 175, and 199 were observed. 
The loss of 204 Da indicated the existence of an acetyl hexose group in each 
compound. Thus, compounds 18, 23, 31, and 34 were identified as luteolin-O-
acetylhexosides. In the MS/MS spectrum, compounds 18, 23, and 31 gave the same 
weak ion at m/z 447 that indicated the loss of acetyl group. However, the ion at m/z 
447 was not observed in the MS/MS spectrum of compound 34. The acylation in 
position 6 of hexose is difficult to break in mass spectrometry [7]. Thus, compound 
34 was further identified as luteolin-O-(6-acetylhexoside). 
Compounds 16 (tR=54.07 min) and 22 (tR=56.96 min) produced the [M − H]
− 
ions at m/z 533. In the MS/MS spectra, they all gave aglycone Y0
− ions at m/z 285. 
In addition, the aglycone was determined as luteolin by the characteristic fragment 
ions at m/z 133, 151, 175, and 199. Their product ions at m/z 489 and 285 by the loss 
of 44 Da (CO2) and 204 Da (acetyl-hexose group) indicated the existence of a 
malonyl-hexose group [7]. Therefore, compounds 16 and 22 were identified as 
luteolin-O-(malonylhexoside). In the MS/MS spectrum, compound 22 gave a weak 
ion at m/z 447, indicating the loss of an acetyl group (remains of malonyl after 
decarboxylation) from an ion at m/z 489. However, the ion at m/z 447 was not 
observed in the MS/MS spectrum of compound 16. Therefore, compound 16 was 




Compounds 2 (tR=45.15 min), 4 (tR=47.53 min), 6 (tR=48.67 min), and 10 
(tR=51.77 min) displayed the same pseudomolecule ions [M − H]
− at m/z 609. The 
aglycone Y0
− ion at m/z 285 and typical product ions at m/z 133, 151, 175, and 199 
in their MS/MS spectrum indicated the aglycone as luteolin. The loss of 324 Da 
could be attributed to the loss of a caffeoyl-hexose unit or a di-hexose unit. Their 
accurate molecular weights by TOF-MS supported their molecular formulae to be 
C28H30O16. Thus, compounds 2, 4,6, and 10 consist of the luteolin moiety with two 
hexose groups (162 Da). In the MS/MS spectrum of compound 2, the high-intensity 
product ion at m/z 447 indicated the two hexose groups substituted for different 
positions on the luteolin moiety. However, only the tiny peak of an ion at m/z 447 
was observed in the MS/MS spectrum of compounds 4, 6, and 10. Therefore, 
compounds 4, 6, and 10 were determined as luteolin-O-hexosylhexosides, and 
compound 2 was identified as luteolin-O-(hexoside, hexoside). 
Compounds 3 (tR=46.95 min) and 5 (tR=48.32 min) exhibited the same [M − 
H]− ions at m/z 623. In their MS/MS spectra, the Y0
− ions at m/z 285 and the 
characteristic fragment ions at m/z 133, 151, 175, and 199 were observed, suggested 
the aglycone was luteolin. The loss of 338 Da indicated ccompounds 3 and 5 consist 
of the luteolin moiety with a hexose group (162 Da) and a glucuronic acid group 
(176 Da). In the MS/MS spectrum of compound 3, a high-intensity product ion at 
m/z 447 was observed, indicating the hexose and glucuronic acid groups substituted 
to different positions on the luteolin moiety. In the MS/MS spectrum of compound 
5, only a weak ion at m/z 447 arising from the loss of 176 Da was observed, 
indicating the existence of the hexose-glucuronic acid group and glucuronic acid in 
the external position. Thus, compounds 3 and 5 were identified as luteolin-O-
(hexoside, glucuronide) and luteolin-O-hexosylglucuronide, respectively. 
63 
 
Compounds 9 (tR=51.47 min) and 12 (tR=52.08 min) gave the same [M − H]
− 
ions at m/z 637. In the MS/MS spectra, they gave the aglycone Y0
− ion at m/z 299. 
In addition, the aglycone was determined as methylluteolin by the characteristic 
fragment ions at m/z 133, 151, 175, 199, and 284. The loss of 338 Da suggested 
compounds 9 and 12 consist of the methylluteolin moiety with a glucuronic acid 
group (176 Da) and a hexose group (162 Da). In their MS/MS spectrum, the weak 
ions at m/z 461 arising from the loss of 176 Da were observed, representing 
glucuronic acid in the external position of the hexose-glucuronic acid group. Thus, 
compounds 9 and 12 were identified as methylluteolin-O-hexosylglucuronide. 
Compounds 29 (tR=59.39 min) and 17 (tR=54.20 min) gave [M − H]
− ions at m/z 
665 and 709. The aglycone Y0
− ion at m/z 285 was observed in both compounds, and 
the aglycone was identified as luteolin by MS/MS spectrum. The weak ion at m/z 
489 ([M − H − glucuronic acid group]−) combined with the Y0
− ion at m/z 285 ([M 
− H − 176 Da − 204 Da]−) suggested compound 29 possessed an acetylhexose-
glucuronic acid group and glucuronic acid was in the external position. Thus, 
compound 29 was identified as luteolin-O-acetylhexosylglucuronide. In the MS/MS 
spectrum of compound 17, product ions of m/z 665 ([M − H − 44 Da]−) and m/z 623 
([M − H − 44 Da − 42 Da]−) indicated the existence of a malonyl group. The high 
intensity product ions of m/z 489 ([M − H − 44 Da − 176 Da]−) and 285 ([M − H − 
176 Da − 44 Da − 204 Da]−) indicated that a glucuronic acid group and a 
malonylhexose group substituted to different positions of luteolin. Thus, compound 







In summary, a rapid and reliable method employing LC-ESI-TOF-MS/MS was 
developed for the identification of flavonoids aerial parts of E. saudiarabica. Based 
on accurate mass measurement and characteristic fragmentation ions, 36 flavonoids, 
including 7 flavonoids originating from galangin, 9 from apigenin, and 20 from 
luteolin, were identified. Among these, 3 compounds are malonyl substituted and 13 
compounds are acetyl substituted. The LC-ESI-TOF-MS/MS method established 
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Conclusion and Future Plan 
The aim of this work was the isolation and structure elucidation of the secondary 
metabolites from the crude extract of two plants: silver maple leaves (Acer 
saccharinum) and aerial parts of the species Euphorbia saudiarabica. First, the 
polyphenolic contents of the silver maple leaves were investigated by using TLC, 
RP-HPLC, and the Folin-Ciocalteau method for quantifying total polyphenols. Next, 
the isolation and purification process was carried out which led to 10 identified 
compounds by means of spectroscopic methods (NMR, and HPLC-DAD). These 
compounds, including six GCGs (ginnalins A-C [1-3], maplexins B, D, and F [4-6]), 
methyl syringate (7), methyl gallate (8), and 3-methoxy-4-hydroxyphenol-1-β-D-(6-
galloyl)-glucopyranoside (9). Additionally, one sesquiterpenoid, namely, pubineroid 
A (10), was isolated and identified. Likewise, the diterpenoids contents of 
Euphorbia saudiarabica were investigated using HPLC-DAD and TLC techniques. 
Next, after multistep of the separation and purification, five new lathyrane-
diterpenoid compounds were elucidated. Additionally, the cytotoxicity effects of 
these compounds were evaluated; all of them exhibited mild to moderate 
cytotoxicity effects. Next, a rapid and reliable method employing LC-ESI-TOF-
MS/MS was developed for the identification of flavonoids from the aerial parts of 
E. saudiarabica which led to 36 reported flavonoid compounds. Finally, future plan 
will be focused on exploring the biological activities of the isolated diterpenoids (1- 
5) from Euphorbia saudiarabica, mainly for their multi-drug resistance (MDR) 
inhibitory effects. In addition, future goals will be focused on investigating other 
Euphorbia species endemic to Saudi Arabia to evaluate their cytotoxicity, as well as 
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no. δH (J in Hz) δC 
1α 2.56 dd (15.0, 9.0) 34.1 
1β 1.67 d (15.0)  
 
2 2.34 m 29.2 








7 5.45 brs 77.2 
8 5.02 dd (11.2, 1.2) 70.2 




11 1.34 dd (8.7, 1.5) 31.0 
12 4.65 dd (4.5, 1.5) 78.1 







16 0.84 d (7.2) 16.0 
17 2.08 s 16.6 
18 1.25 s 17.0 
19 6.13 s 103.1 
   










1.87 s 19.5 
12-OAc   












1'  129.5 
2' 7.99 m 129.3 
3' 7.42 ddd (7.2, 7.2, 1) 128.5 
4' 7.55 dddd (7.5, 7.5, 1.5, 1.5) 133.3 
5' 7.42 ddd (7.2, 7.2, 1.5) 128.5 
6' 7.99 m 129.3 
7' - - 
 
  



























































no. δH (J in Hz) δC 
1α 2.59 dd (14.7, 9.0)  34.1 
1β 1.72 d (15.0)  
 
2 2.36 m 29.3 








7 5.22 brs 77.1 
8 4.92 d (11.1) 70.2 




11 1.25 m 30.9 
12 4.58 d (4.8) 78.0 







16 0.84 d (7.5) 16.0 
17 1.97 d (1.8) 16.5 
18 1.20 s 17.0 
19 6.03 s 103.0 
   








 1.98 s 19.9 
12-OAc   















3' 6.86 q (6.6)  138.4 
4' 1.74 d (6.6) 13.2 
5' 1.76 s 10.8 
6' - - 





















































no. δH (J in Hz) δC 
1α 2.70 dd (14.7, 9.0)  31.1 
1β 1.60 d (14.7)  
2 2.41 m 29.3 
3 5.13 d (8.7) 76.8 
4  71.0 
5 5.43 m 117.6 
6  138.7 
7 5.04 d (1.8) 76.4 
8 4.54 dd (10.8, 1.8) 70.7 
9 1.30 dd (10.8, 9.0) 25.0 
10  21.6 
11 1.15 dd (11.1, 9.0) 30.9 
12 4.84 dd (11.1, 7.8) 69.4 
13 2.82 dq (7.5, 7.2) 43.0 
14  207.0 
15  73.4 
16 0.84 d (7.5) 15.9 
17 1.96 d (1.5) 16.2 
18 1.00 s 23.2 
19 19α: 4.01 d (12.0)  64.7 
 19β: 3.46 d (12.0)  
20 0.92 d (7.2) 12.4 
3-OAc  170.6 
 2.00 s 19.7 
8-OAc  170.4 
 1.94 s 19.0 
12-OAc  170.8 
 1.89 s 19.33 
19-OAc  171.3 
 1.88 s 19.5 
7-R  O-Bzl 
C=O  170.5 
1'  134.1 
2'  129.1 
3' 7.20 5H m 126.8 
4'  128.2 
5'  126.8 
6'  129.1 
7' 3.65 s 40.7 
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no. δH (J in Hz) δC 
1α 2.03 dd (13.5, 10.5) 32.6 
  1β 1.85 d (14.0) 
 
2 1.84 m 33.2 








7 5.43 d (1.5) 75.9 
8 5.14 dd (11.0, 2.0) 72.5 




11 1.37 dd (11.5, 9.0) 31.6 
12 5.08 dd (11.5, 3.5) 69.5 







16 0.88 d (7.0) 13.0 
17 2.11 d (1.5) 17.7 
18 1.16 s 24.4 
19α 3.88 d (12.0) 64.9 
19β 3.62 d (12.0)  
20 0.95 d (7.0) 13.4 
3-OAc 3-OH: 5.32 d (6.5) 
 
   
12-OAc  170.3 









C=O  166.3 
1'   
2'  128.2 
3' 6.89 q (7.0) 139.0 
4' 1.79 d (7.0) 14.8  
5' 1.78 s 12.5 
6' - - 
8-R  O-Bz 
C=O   165.2 
1''  129.8 
2'' 7.87 dd (7.5, 1.5) 129.6 
3'' 7.53 dd (7.5, 7.5) 129.4 
4'' 7.66 m 134.0 
5'' 7.53 dd (7.5, 7.5) 129.4 
6'' 7.87 dd (7.5, 1.5) 125.6 
 






no. δH (J in Hz) δC 
1α 2.19, m 31.8 
  1β 1.90, m  
2 1.90 m 33.0 
3 3.90 d (5.0) 75.7 
4  73.2 
5 6.16 s 117.8 
6  136.8 
7 5.29 d (1.5) 76.2 
8 4.82 dd (11.0, 1.5) 70.9 
9 1.64 dd (11.0, 9.0) 25.6 
10  21.6 
11 1.42 dd (11.0, 9.0) 31.3 
12 5.01 dd (11.5, 3.5) 69.5 
13 3.04 qd (7.0, 3.5) 43.2 
14  207.8 
15  73.0 
16 0.99 d (6.5) 11.0 
17 2.13 s 16.4 
18 1.16 s 23.2 
19α 4.08 d (12.0) 64.8 
19β 3.60 d (12.0)  
20 1.04 d (7.0) 12.3 
3-OAc   
 
  
12-OAc  170.8 
 2.10 s 19.7 
19- OAc  171.2 
 
1.93 s 19.3 
7-R  O-Ang 
C=O  166.6 
1'   
2'  128.1 
3' 6.95 m 138.3 
4' 1.84 d (7.0) 13.1 
5' 1.87 s 10.8 
6' - - 
8-R  O-Ang 
C=O   166.9 
1''   
2''  128.0 
3'' 6.83 m 138.3 
4'' 1.81 d (7.5) 13.1 
5'' 1.80 s 10.6 
6'' - - 
 





































































































































































































































































































































































































































































































































(+)-HRESIMS m/z 691.2751 [M + Na]+ (calcd for C36H44O12Na, 691.2730).  
 





























































































































































































































































































































































































Table S6. Polyphenol content assay of silver maple fractions. 
Table S7. Compounds (1-10) retention time (Rt).  
Figures 
Figure S48. Extraction and isolation of compounds 1, 7 and 10 from silver maple 
leaves (Acer saccharinum).  
Figure S49.  Chemical Structures of compounds 1-10 isolated from silver maple 
leaves.  
Figure S50. HPLC-DAD chromatogram of ethyl acetate extract of silver maple 
leaves showing the isolated compounds (1-10). 
Figure S51. The 1H NMR spectrum of compound 10 




Table S8. The fixed wavelength of all compounds (1-5)  
Figures 
Figure S53. The isolation Scheme of compound 1-5. 
Figure S53. The HPLC profile for Euphorbia saudiarabica crude extract. 
Figure S54. The HPLC-DAD profile for n-hexanes extract. 
Figure S55. The HPLC-DAD profile for ethyl acetate extract. 
Figure S56. The HPLC-DAD profile for butanol extract. 
Figure S57. The HPLC-DAD profile for acetonitrile extract. 
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Figure S58. The HPLC-DAD profile for water extract. 
Figure S59. The HPLC-DAD profile for Pure compound 1 
Figure S60. The HPLC-DAD profile for Pure compound 2 
Figure S61. The HP-DAD profile for Pure compound 3 
Figure S62. The HPLC-DAD profile for Pure compound 4 
Figure S63. The HPLC-DAD profile for Pure compound 5 
Figure S64. The UV-vis spectrum for compound 1 
Figure S65. The UV-vis spectrum for compound 2 
Figure S66. The UV-vis spectrum for compound 3 
Figure S67. The UV-vis spectrum for compound 4 
Figure S68. The UV-vis spectrum for compound 5 
Figure S69. The CD spectrum for compound 2 
Figure S70. The CD spectrum for compound 4 
Figure S71. The CD spectrum for compound 5 
Figure S72. 1H NMR (500 and 125 MHz, CD3OD) spectra of 6 
Figure S73. 13C NMR (500 and 125 MHz, CD3OD) spectra of 6 
Figure S74. 1H-1H COSY (500 and 125 MHz, CD3OD) spectra of 6 
Figure S75. HSQC (500 and 125 MHz, CD3OD) spectra of 6 
Figure S76. HMBC (500 and 125 MHz, CD3OD) spectra of 6 
Figure S77. NOESY (500 and 125 MHz, CD3OD) spectra of 6 








Label Polyphenols % 
Methanol Extraction 39.0 
n-Hexanes  Fraction 7.8 
Ethyl Acetate Fraction 58.8 









Cmpds Chemical name UV (nm) 
1 Ginnalin A 215, 276 
2 Ginnalin B 217, 272 
3 Ginnalin C 215, 276 
4 Maplexin B 215, 276 
5 Maplexin D 215, 278 
6 Maplexin F 217, 278 
7 methyl gallate 224, 275 





















Figure S48. Extraction and isolation scheme of compounds 1, 7 and 10 from silver 


























Figure S50. HPLC-DAD chromatogram of ethyl acetate extract of silver maple 













































MW loge Wavelengh 
 
1 
0.8053 1.2 610 5.61 208 
0.7422 8 610 4.75 272 
2 0.5312 1.25 588 5.40 203 
0.5206 100 588 3.49 270 
 
3 
0.6443 5 668 4.93 210 
0.7734 100 668 3.71 270 
 
4 
0.5601 10 652 4.56 200 
0.2421 100 652 3.20 270 
 
5 
0.66 50 630 3.92 222 


















































































































































































































































































































































































































































Figure S79. HRESI (+) MS spectra of 6 
 
 
 
 
 
 
 
 
